A detailed history of Banque Cantonale Vaudoise transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 16,000 shares of BMRN stock, worth $1.07 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
16,000
Previous 16,350 2.14%
Holding current value
$1.07 Million
Previous $1.35 Million 16.42%
% of portfolio
0.05%
Previous 0.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$69.02 - $93.84 $24,157 - $32,844
-350 Reduced 2.14%
16,000 $1.13 Million
Q1 2024

Apr 10, 2024

SELL
$83.81 - $99.0 $34,697 - $40,986
-414 Reduced 2.47%
16,350 $1.43 Million
Q4 2023

Feb 07, 2024

SELL
$76.22 - $98.51 $218,751 - $282,723
-2,870 Reduced 14.62%
16,764 $1.62 Million
Q3 2023

Nov 08, 2023

SELL
$85.07 - $94.48 $45,597 - $50,641
-536 Reduced 2.66%
19,634 $1.74 Million
Q2 2023

Aug 09, 2023

SELL
$86.68 - $100.3 $4,334 - $5,015
-50 Reduced 0.25%
20,170 $1.75 Million
Q1 2023

Apr 20, 2023

SELL
$87.74 - $117.27 $333,412 - $445,626
-3,800 Reduced 15.82%
20,220 $1.97 Million
Q4 2022

Feb 10, 2023

BUY
$80.93 - $108.63 $302,840 - $406,493
3,742 Added 18.45%
24,020 $2.49 Million
Q3 2022

Oct 17, 2022

BUY
$82.16 - $96.94 $42,887 - $50,602
522 Added 2.64%
20,278 $1.72 Million
Q2 2022

Aug 02, 2022

SELL
$71.48 - $86.85 $50,036 - $60,794
-700 Reduced 3.42%
19,756 $1.64 Million
Q4 2021

Feb 14, 2022

SELL
$71.72 - $91.47 $68,994 - $87,994
-962 Reduced 4.49%
20,456 $1.81 Million
Q3 2021

Oct 29, 2021

BUY
$74.77 - $85.47 $1.16 Million - $1.32 Million
15,500 Added 261.91%
21,418 $1.66 Million
Q2 2021

Aug 11, 2021

SELL
$75.51 - $84.79 $182,356 - $204,767
-2,415 Reduced 28.98%
5,918 $494,000
Q1 2021

May 11, 2021

SELL
$74.73 - $90.69 $431,789 - $524,006
-5,778 Reduced 40.95%
8,333 $628,000
Q4 2020

Feb 05, 2021

BUY
$72.61 - $90.2 $102,670 - $127,542
1,414 Added 11.14%
14,111 $1.24 Million
Q3 2020

Oct 30, 2020

SELL
$71.87 - $131.03 $148,339 - $270,445
-2,064 Reduced 13.98%
12,697 $965,000
Q2 2020

Jul 22, 2020

BUY
$79.55 - $124.22 $601,159 - $938,730
7,557 Added 104.9%
14,761 $1.82 Million
Q1 2020

May 14, 2020

SELL
$71.37 - $96.85 $29,689 - $40,289
-416 Reduced 5.46%
7,204 $608,000
Q4 2019

Feb 10, 2020

BUY
$64.27 - $86.37 $489,737 - $658,139
7,620 New
7,620 $644,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.